Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Philip

Showing results (371-380 of 441) with videos related to

Pageof 45
Sort By:
Progress in Clinical and Biological Research|January 1, 1991
Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patientsJ M Zucker, T Philip, J L Bernard, et al.
Cancer Treatment Reviews|June 1, 1989
Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre studyG Stoter, S D Fosså, C Rugarli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology SocietyC Patte, T Philip, C Rodary, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)T Philip, F Chauvin, D Bron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 childrenC Patte, T Philip, C Rodary, et al.
Lancet (London, England)|March 9, 1985
Purged autologous bone marrow transplantation in 25 cases of very poor prognosis neuroblastomaT Philip, J L Bernard, J M Zucker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trialsT Bachelot, I Ray-Coquard, G Catimel, et al.
Medical and Pediatric Oncology|January 1, 1987
High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II studyC R Pinkerton, T Philip, P Biron, et al.
Blood|April 15, 1993
Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Société Française d'Oncologie PédiatriqueT Philip, O Hartmann, R Pinkerton, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 21, 2010
GPI-1046 increases presenilin-1 expression and restores NMDA channel activityJoseph P Steiner, Kathryn B Payne, Christopher Drummond Main, et al.
Pageof 45

Showing results (371-380 of 441) with videos related to

Sort By:
Pageof 45
Progress in Clinical and Biological Research|January 1, 1991
Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patientsJ M Zucker, T Philip, J L Bernard, et al.
Cancer Treatment Reviews|June 1, 1989
Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre studyG Stoter, S D Fosså, C Rugarli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology SocietyC Patte, T Philip, C Rodary, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)T Philip, F Chauvin, D Bron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 childrenC Patte, T Philip, C Rodary, et al.
Lancet (London, England)|March 9, 1985
Purged autologous bone marrow transplantation in 25 cases of very poor prognosis neuroblastomaT Philip, J L Bernard, J M Zucker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trialsT Bachelot, I Ray-Coquard, G Catimel, et al.
Medical and Pediatric Oncology|January 1, 1987
High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II studyC R Pinkerton, T Philip, P Biron, et al.
Blood|April 15, 1993
Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Société Française d'Oncologie PédiatriqueT Philip, O Hartmann, R Pinkerton, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 21, 2010
GPI-1046 increases presenilin-1 expression and restores NMDA channel activityJoseph P Steiner, Kathryn B Payne, Christopher Drummond Main, et al.
Pageof 45